SAMUELA FANUA: Open Payments
NPI 1518539196 · STOCKTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,163 in 86 payments from 23 companies in 2025. Trend: 2023 $1,398 · 2024 $1,623 · 2025 $2,163
Food & beverage: $2,142Education: $20
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $270 |
| Novartis Pharmaceuticals Corporation | 15 | $260 |
| Merck Sharp & Dohme LLC | 10 | $226 |
| Novo Nordisk Inc | 7 | $173 |
| Amgen Inc. | 10 | $167 |
| BridgeBio Pharma, Inc. | 1 | $148 |
| AtriCure, Inc. | 2 | $143 |
| Alnylam Pharmaceuticals Inc. | 4 | $112 |
| Artivion, Inc. | 1 | $99 |
| PFIZER INC. | 4 | $94 |
Products named: LEQVIO, REPATHA, Adempas, Attruby, VERQUVO, ATRICLIP LAA EXCLUSION SYSTEM, Kerendia, AMVUTTRA.
Industry payments across CA — which companies pay providers there.
